Results 1 to 10 of about 4,551,719 (377)

The Future of Clinical Phage Therapy in the United Kingdom

open access: yesViruses, 2023
Bacteriophage (phage) therapy is a promising alternative antimicrobial strategy with the potential to transform the way bacterial infections are treated. In the United Kingdom, phages are classed as a biological medicine.
Joshua D. Jones   +4 more
doaj   +2 more sources

A Comprehensive Review on Phage Therapy and Phage-Based Drug Development. [PDF]

open access: yesAntibiotics (Basel)
Phage therapy, the use of bacteriophages (phages) to treat bacterial infections, is regaining momentum as a promising weapon against the rising threat of multidrug-resistant (MDR) bacteria.
Cui L   +10 more
europepmc   +2 more sources

Perception of phage therapy and research across selected professional and social groups in Poland [PDF]

open access: yesFrontiers in Public Health
There is no doubt that in the last 15 years phage therapy has re-emerged from the shadow of antibiotics, from the perspective of both scientists and various patient advocacy groups.
Maciej Żaczek   +8 more
doaj   +2 more sources

Efficacy of systemic temozolomide‐activated phage‐targeted gene therapy in human glioblastoma

open access: goldEMBO Molecular Medicine, 2019
Glioblastoma multiforme (GBM) is the most lethal primary intracranial malignant neoplasm in adults and most resistant to treatment. Integration of gene therapy and chemotherapy, chemovirotherapy, has the potential to improve treatment. We have introduced
Justyna Magdalena Przystal   +12 more
doaj   +2 more sources

Current challenges and future opportunities of phage therapy [PDF]

open access: greenFEMS Microbiology Reviews, 2020
Antibiotic resistance is a major public health challenge worldwide, whose implications for global health might be devastating if novel antibacterial strategies are not quickly developed.
Diana P. Pires   +4 more
openalex   +2 more sources

Case Report: Chronic Bacterial Prostatitis Treated With Phage Therapy After Multiple Failed Antibiotic Treatments

open access: yesFrontiers in Pharmacology, 2021
Background: Chronic Bacterial Prostatitis (CBP) is an inflammatory condition caused by a persistent bacterial infection of the prostate gland and its surrounding areas in the male pelvic region. It is most common in men under 50 years of age.
Apurva Virmani Johri   +5 more
doaj   +1 more source

Case report: Successful treatment of recurrent E. coli infection with bacteriophage therapy for patient suffering from chronic bacterial prostatitis

open access: yesFrontiers in Pharmacology, 2023
Background: Chronic Bacterial Prostatitis (CBP) is inflammation of the prostate caused by bacterial infection. An estimated 8.2% of men have prostatitis, most commonly under the age of 50.
Apurva Virmani Johri   +6 more
doaj   +1 more source

DNA Dye Sytox Green in Detection of Bacteriolytic Activity: High Speed, Precision and Sensitivity Demonstrated With Endolysins

open access: yesFrontiers in Microbiology, 2021
Introduction: Increasing number of deaths from multi-drug resistant bacterial infections has caused both the World Health Organization and the Centers for Disease Control and Prevention to repeatedly call for development of new, non-traditional ...
Marek Harhala   +11 more
doaj   +1 more source

Phage Therapy—Challenges, Opportunities and Future Prospects

open access: yesPharmaceuticals, 2023
The increasing drug resistance of bacteria to commonly used antibiotics creates the need to search for and develop alternative forms of treatment. Phage therapy fits this trend perfectly.
Beata Zalewska-Piątek
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy